WELLS FARGO & COMPANY/MN - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$29,242
-91.4%
23,025
-77.6%
0.00%
Q2 2023$338,551
-15.3%
102,903
+5.8%
0.00%
Q1 2023$399,800
+3898.0%
97,275
+6131.6%
0.00%
Q3 2022$10,000
+100.0%
1,561
+37.2%
0.00%
Q2 2022$5,000
-93.0%
1,138
-93.6%
0.00%
Q1 2022$71,000
-72.6%
17,734
-57.5%
0.00%
Q4 2021$259,000
+418.0%
41,742
+678.8%
0.00%
Q3 2021$50,000
+4900.0%
5,360
+10207.7%
0.00%
Q2 2021$1,000
-99.7%
52
-99.8%
0.00%
Q1 2021$345,000
-89.5%
21,347
-82.7%
0.00%
-100.0%
Q4 2020$3,275,000
+36.2%
123,048
-4.7%
0.00%0.0%
Q3 2020$2,405,000
-14.5%
129,170
-13.9%
0.00%0.0%
Q2 2020$2,812,000
+530.5%
150,088
+96.4%
0.00%
Q1 2020$446,000
+88.2%
76,434
+84.6%
0.00%
Q4 2019$237,000
+203.8%
41,395
-16.9%
0.00%
Q3 2019$78,000
+310.5%
49,835
+946.1%
0.00%
Q2 2019$19,000
-36.7%
4,764
-16.8%
0.00%
Q1 2019$30,000
+30.4%
5,727
-0.3%
0.00%
Q4 2018$23,000
-86.1%
5,746
-65.5%
0.00%
Q3 2018$166,000
-44.1%
16,675
+0.6%
0.00%
Q2 2018$297,000
+237.5%
16,576
+196.1%
0.00%
Q1 2018$88,000
+15.8%
5,598
+20.3%
0.00%
Q4 2017$76,000
+1166.7%
4,655
+1222.4%
0.00%
Q3 2017$6,0003520.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 4,005,600$64,810,0006.21%
Bain Capital Life Sciences Investors, LLC 3,695,667$59,796,0003.39%
COMMODORE CAPITAL LP 429,228$6,945,0002.77%
ACUTA CAPITAL PARTNERS, LLC 357,689$5,787,0002.09%
Avoro Capital Advisors LLC 6,800,000$110,024,0001.90%
Ghost Tree Capital, LLC 450,000$7,281,0001.71%
RHO CAPITAL PARTNERS INC 796,458$12,887,0001.24%
Rock Springs Capital Management LP 2,775,127$44,902,0000.98%
Sio Capital Management, LLC 157,259$2,544,0000.52%
Bellevue Group AG 2,850,010$46,113,0000.49%
View complete list of MERSANA THERAPEUTICS INC shareholders